Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

idarubicin hydrochloride

View Patient Information

The hydrochloride salt of the anthracycline antineoplastic antibiotic idarubicin. Idarubicin intercalates into DNA and inhibits topoisomerase II, thereby inhibiting DNA replication and ultimately, interfering with RNA and protein synthesis. Due to its high lipophilicity, idarubicin penetrates cell membranes more efficiently than other anthracycline antibiotic compounds

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	4-demethoxydaunomycin idarubicin HCl
US brand name:	Idamycin Idamycin PFS
Foreign brand name:	Zavedos
Code name:	IMI-30 SC-33428

idarubicin hydrochloride

Search NCI's Drug Dictionary